Product Information

FONDAPARINUX 2.5 MG/0.5 ML SYR is a generic product labeled by Eugia US LLC, priced at $22.1623 per ML under NDC 55150023010. Its NADAC has been published 170 times since Mar 18, 2020.

FDA first approved this application on Dec 26, 2017. Its Orange Book therapeutic-equivalence code is AP.

FONDAPARINUX 2.5 MG/0.5 ML SYR

FONDAPARINUX SODIUM
$22.1623per ML

Strength

2.5 mg/.5mL

Manufacturer

Eugia US LLC

NDC

55150023010

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

FONDAPARINUX SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA206918

FDA Approved

12/26/2017

TE Code

AP

On Market Since

12/26/2017

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price Statistics

The NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has been published 170 times since Mar 18, 2020, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.

Current price$22.1623 per ML
All-time high$40.3736 (Mar 10, 2021)
All-time low$18.9706 (Apr 22, 2026)
52-week high$26.9533
52-week low$18.9706
Median price$27.3476
Average price$29.6553
Largest weekly change-39.2% (May 22, 2024)
Weeks tracked170
Tracking sinceMar 18, 2020

Price History

1W

+3.2%

1M

+3.2%

3M

+12.7%

6M

+5.0%

1Y

-17.8%

3Y

-45.1%

5Y

-45.1%

All

-45.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FONDAPARINUX SODIUM market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of FONDAPARINUX 2.5 MG/0.5 ML SYR?

The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 2.5 MG/0.5 ML SYR, manufactured by Eugia US LLC, is $22.1623 per ML (NDC 55150023010), effective Aug 19, 2026.

How has the price of FONDAPARINUX 2.5 MG/0.5 ML SYR changed over time?

Over the history we have for it, the NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has declined 45.1%. It has been tracked across 170 weekly CMS publications since Mar 18, 2020.

What are the highest and lowest recorded NADAC prices for FONDAPARINUX 2.5 MG/0.5 ML SYR?

Since Mar 18, 2020, the NADAC for FONDAPARINUX 2.5 MG/0.5 ML SYR has ranged from a low of $18.9706 (Apr 22, 2026) to a high of $40.3736 (Mar 10, 2021), with a median of $27.3476 per ML.

Are there cheaper alternatives to FONDAPARINUX 2.5 MG/0.5 ML SYR?

No other NADAC-published product currently shares the active ingredient and strength of FONDAPARINUX 2.5 MG/0.5 ML SYR in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures FONDAPARINUX 2.5 MG/0.5 ML SYR?

FONDAPARINUX 2.5 MG/0.5 ML SYR (NDC 55150023010) is labeled by Eugia US LLC, and CMS classifies it as a generic product.